Tom LoBianco, national campaign reporter and author of '24sight' on Substack, weighs in on former President Trump's win in Iowa, the state of Ron DeSantis and Nikki Haley's campaign, and the impact of Vivek Ramaswamy dropping out of the race.
Share:
More In Business
On the Scene: Post-Holiday Shopping at American Dream Mall
New Jersey's American Dream Mall continues to offer holiday experiences.
Maine Storm Has Delayed a Key Vote on California-Style Limits for Gas Vehicles
The rollout of potential new electric vehicle goals in Maine has been pushed back by a year because of a recent storm.
Tips on How to Return Unwanted Gifts
Tips on How to Return Unwanted Gifts
What Investors Are Looking Ahead to This Week
What Investors Are Looking Ahead to This Week
Holiday Travel Mostly Uninterrupted Across U.S.
Holiday Travel Mostly Uninterrupted Across U.S.
Holiday Travel Mostly Nice, but With Some Naughty Disruptions Again on Southwest Airlines
Conditions have been mostly nice for travelers flying ahead of and on Christmas Day, but some naughty disruptions plagued those flying with Southwest Airlines again this year.
The Secret Life of Gift Cards: Here's What Happens to the Billions That Go Unspent Each Year
Gift cards make great stocking stuffers — just as long as you don't stuff them in a drawer and forget about them after the holidays.
Big Business This Week: Warner Bros Discovery + Paramount Rumor, Steel Titans Deal and More
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Bristol Myers Squibb to Buy Koruna Therapeutics for $14 Billion
Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
